Intensity Therapeutics Ownership | Who Owns Intensity Therapeutics?

Intensity Therapeutics Ownership Summary

Intensity Therapeutics is owned by 15.67% institutional investors, 10.38% insiders, and 73.95% retail investors. Sapient capital is the largest institutional shareholder, holding 5.18% of INTS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.44% of its assets in Intensity Therapeutics shares.

INTS Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Intensity Therapeutics	15.67%	10.38%	73.95%
Sector	Healthcare Stocks	42.53%	10.81%	46.67%
Industry	Biotech Stocks	45.24%	10.75%	44.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Sapient capital	976.80K	5.18%	$239.71K
Sentinus	481.18K	2.55%	$116.78K
Geode capital management	258.89K	1.37%	$62.83K
Vanguard group	255.93K	1.36%	$62.19K
Mesirow financial investment management	200.00K	1.06%	$48.54K
Ubs group	136.23K	0.72%	$33.10K
Brown advisory	130.07K	0.69%	$31.57K
Sigma planning	69.17K	0.37%	$16.79K
Warberg asset management	60.00K	0.32%	$14.56M
Stonebridge financial group	54.38K	0.29%	$13.20K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Sentinus	481.18K	0.03%	$116.78K
Sapient capital	976.80K	0.00%	$239.71K
Warberg asset management	60.00K	0.00%	$14.56M
Sassicaia capital advisers	20.00K	0.00%	$4.85K
Scientech research	24.73K	0.00%	$6.00K
Qtr family wealth	17.42K	0.00%	$4.23K
One charles private wealth services	31.80K	0.00%	$7.72K
Ewa	19.22K	0.00%	$4.66K
Stonebridge financial group	54.38K	0.00%	$13.20K
Mesirow financial investment management	200.00K	0.00%	$48.54K

Top Buyers

Holder	Shares	% Assets	Change
Sentinus	481.18K	0.03%	281.87K
Vanguard group	255.93K	-	215.35K
Geode capital management	258.89K	-	186.08K
Ubs group	136.23K	-	127.00K
Mesirow financial investment management	200.00K	0.00%	90.00K

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-872.55K
Jane street group	-	-	-44.90K
Hrt financial lp	-	-	-24.90K
Xtx topco	-	-	-24.55K
Blackrock funding, inc. /de	-	-	-21.84K

New Positions

Holder	Shares	% Assets	Change	Value
Iht wealth management	47.48K	0.00%	47.48K	$11.52K
Citigroup	44.58K	-	44.58K	$10.82K
Scientech research	24.73K	0.00%	24.73K	$6.00K
Sassicaia capital advisers	20.00K	0.00%	20.00K	$4.85K
Two sigma securities	18.45K	0.00%	18.45K	$4.48K

Sold Out

Holder	Change
Jpmorgan chase	-15.00
Fmr	-100.00
Cubist systematic strategies	-11.67K
Boothbay fund management	-15.00K
Blackrock funding, inc. /de	-21.84K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	25	-7.41%	2,956,433	49.41%	15	14.25%	15	-11.76%	1	-50.00%
Jun 30, 2025	27	28.57%	1,978,698	-23.56%	10	3.60%	17	54.55%	2	-50.00%
Mar 31, 2025	21	5.00%	2,588,459	-4.84%	17	4.46%	11	57.14%	4	-20.00%
Dec 31, 2024	20	-	2,720,161	56.32%	19	12.31%	7	16.67%	5	-
Sep 30, 2024	20	-9.09%	1,740,070	3.65%	12	8.41%	6	-33.33%	5	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	265.38K	1.44%	-
iShares Micro-Cap ETF	18.04K	0.10%	-
Fidelity Extended Market Index	43.18K	0.09%	-
Vanguard Institutional Extnd Mkt Idx Tr	27.88K	0.06%	-12.71K
NT Ext Equity Mkt Idx Fd - L	7.82K	0.03%	-
Northern Trust Extended Eq Market Idx	7.82K	0.03%	-
NT Ext Equity Mkt Idx Fd - NL	5.95K	0.02%	-
Fidelity Series Total Market Index	10.69K	0.02%	-
Spartan Extended Market Index Pool F	5.86K	0.02%	-
Fidelity Total Market Index	9.42K	0.02%	-

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2024 Q4	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-

INTS Ownership FAQ

Who Owns Intensity Therapeutics?

Intensity Therapeutics shareholders are primarily institutional investors at 15.67%, followed by 10.38% insiders and 73.95% retail investors. The average institutional ownership in Intensity Therapeutics's industry, Biotech Stocks , is 45.24%, which Intensity Therapeutics falls below.

Who owns the most shares of Intensity Therapeutics?

Intensity Therapeutics’s largest shareholders are Sapient capital (976.8K shares, 5.18%), Sentinus (481.18K shares, 2.55%), and Geode capital management (258.89K shares, 1.37%). Together, they hold 9.10% of Intensity Therapeutics’s total shares outstanding.

Does Blackrock own Intensity Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Intensity Therapeutics.

Who is Intensity Therapeutics’s biggest shareholder by percentage of total assets invested?

Sentinus is Intensity Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.03% of its assets in 481.18K Intensity Therapeutics shares, valued at 116.78K$.

Who is the top mutual fund holder of Intensity Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Intensity Therapeutics shares, with 1.44% of its total shares outstanding invested in 265.38K Intensity Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools